$0.0120
-0.00200-14.29%
At close: -
$0.0104
-0.00160-13.33%
After Hours: Jul 28, 8:54 AM EDT
Comments
Loading...
BioTech Medics Analyst Ratings and Price Targets | OTC:BMCS | Benzinga
BioTech Medics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BioTech Medics Corp from these most-recent analyst ratings.
Analyst Ratings for BioTech Medics
Data brought to you by Benzinga APIs
FAQ
What is the target price for BioTech Medics (BMCS) stock?
There is no price target for BioTech Medics
What is the most recent analyst rating for BioTech Medics (BMCS)?
There is no analyst for BioTech Medics
When was the last upgrade for BioTech Medics (BMCS)?
There is no last upgrade for BioTech Medics
When was the last downgrade for BioTech Medics (BMCS)?
There is no last downgrade for BioTech Medics.
When is the next analyst rating going to be posted or updated for BioTech Medics (BMCS)?
There is no next analyst rating for BioTech Medics.
Is the Analyst Rating BioTech Medics (BMCS) correct?
There is no next analyst rating for BioTech Medics.
Browse analyst ratings and price targets on all stocks.